RxDoctor Payments Data

Melanie Jones

Acute Care · Midland, TXNPI 1548842453

Payments from drug & device makers

$5,090in general payments, 2019–2025

Across 236 payments — averaging $21.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$560
  • AstraZeneca$348
  • UCB, Inc.$341
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$242
  • Inspire Medical Systems, Inc.$227
  • plus $2K from 29 others

What the payments were for

  • Food & beverage$5,04599%
  • Education$451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,090 in reported general payments places this provider in the 90th percentile of 2,323 acute care providers in Texas.

See all acute care providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin53$792
Tizanidine Hcl61$681
Tramadol Hcl53$566
Pregabalin22$532
Memantine Hcl17$411
Duloxetine Hcl11$220
Baclofen20$179
Topiramate15$60
Meloxicam15$20

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Upsher-smith Laboratories LLCTopiramate$57$6015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,323 acute care providers in Texas.

Other acute care in Midland

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →